First line MM therapy among 105 patients in control arm that required therapy:(a) VRd/KRd: 32 (30.5%)(b) Total patients with anti-CD38-containing regimens, including all subsequent treatments: 35 (17.9%). Here, CD38 is linked to Miyoshi myopathy.